Navigation Links
North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia

MANHASSET, NY (PRWEB) July 25, 2013

The Feinstein Institute for Medical Research announced today it will receive a $250,000 grant aimed at gaining a better understanding of chronic lymphocytic leukemia (CLL) and other blood cancers.

The two-year grant from the Lymphoma Research Foundation (LRF), the nation’s largest non-profit organization devoted to funding innovative lymphoma research, was awarded to
Nicholas Chiorazzi, MD, head of the Karches Center for Chronic Lymphocytic Leukemia Research at the Feinstein Institute. Dr. Chiorazzi’s lab and that of his collaborator, Dr. Matthew D. Scharff at the Albert Einstein College of Medicine in the Bronx, will utilize the funds to research gene expression and DNA methylation signatures linked to in vivo CLL/small lymphocytic lymphoma B-cell kinetics and outcome.

“I am grateful to the Lymphoma Research Foundation for supporting this research so that Dr. Scharff and I can work to better understand CLL and ultimately find a new, improved treatment for the devastating disease,” said Dr. Chiorazzi.

The grant received from LRF is a portion of a $2.15 million grant divided among seven scientists investigating the biology of or new therapies for lymphoma.

“As evident in our recent funding of more than $2 million in research, the Lymphoma Research Foundation is dedicated to finding a cure for lymphoma through an aggressively funded research program,” said Diane Blum, LRF chief executive officer. “We remain grateful to our supporters whose generosity enables the Foundation to work toward its mission of eradicating lymphoma through innovative research.”

Recommendations for research funding were made by the LRF Scientific Advisory Board, which is comprised of the world’s leading lymphoma researchers and oncologists. The award recommendations were then approved by the LRF Board of Directors.
Grantees include:

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $54 million in lymphoma-specific research. For additional information on LRF’s research, education and services, please visit

About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Keeping Kids Safe: North Shore-LIJ Trains Nassau Police and Youth Explorers in Car Seat Safety
2. Hofstra North Shore-LIJ Medical Scholars Pipeline Program Serves Up a Summer of Enriching Experiences to 61 High School Students
3. Best 2013 Charlotte, North Carolina Security System Companies Rated by
4. Worldwide Power Products Announces Strategic Partnership with Northstar Recovery Services; Attains Registered Vendor Status
5. Hollywood Comes to Thomasville North Carolina’s Favorite Restaurant -Southern Sisters
6. Three North Shore-LIJ Health System Hospitals Called Leaders in LGBT Equality
7. HCT Packaging, Inc. to Present Cutting Edge Packaging Innovations at CosmoProf North America 2013
8. Long Island Bike Challenge Rides to Raise Money for North Shore-LIJ's Feinstein Institute of Medical Research
9. Westchester County Surgery Team Performs Region's First Robot-Assisted Splenectomy at Northern Westchester Hospital
10. Katz Women’s Hospital at North Shore Earns LEED Platinum Green Building Certification for Second Time
11. North America Market for Obesity Management & Weight Loss 2017 Forecasts in New Research Report at
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology: